The Health Effect 2026 study by Worldpanel by Numerator reported that Mexican households where at least one person uses GLP-1 medications reduced their purchases of high-calorie products by 20% over a six-month period. ^[1] The study found that 3.8% of Mexican households currently have at least one person using GLP-1 drugs, while another 5.7% consider using them, pointing to a potential short-term increase of more than 100% in user households. ^[2] The study indicates that 36% of people in Mexico who stopped using GLP-1 treatments consider it probable or definite that they will resume using them. ^[3] A study published in the Journal of Dental Sciences found that among older adults, a lower ability to chew is associated with lower cognitive scores. ^[4] An investigation published in PubMed using tomography showed increased blood flow in different brain regions, including sensorimotor areas, supplementary motor regions, the insula, the cerebellum, and the striatum, during chewing. ^[5] Chewing is a complex motor activity that involves coordination between the nervous system and oral structures, generating sensory stimuli and muscle activity that communicate with the nervous system. ^[6] Researchers concluded that while there is an association between adequate chewing function and better cognitive status in older adults, chewing itself is not yet considered a strategy to prevent diseases like Alzheimer's. ^[7] Users of these treatments in Mexico are primarily young, with 35% of users being under the age of 35. ^[8]